Skip to main content

Aldeyra Therapeutics, Inc.

ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001341235

No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $78.2M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Aldeyra Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Aldeyra Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Aldeyra Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Douglas RichardDirector195,000Jun 11, 20262
Deptula-Hicks Darlene MDirector–Jun 11, 20261
Phillips Gary M.Director14,812Jun 11, 20261
Clark William DDirector–Jun 11, 20261
Walker NealDirector15,854Jun 11, 20261
Bronstein BenDirector28,248Jun 11, 20261
Miller-Rich NancyDirector922Jun 11, 20261
Brady Todd CPresident and CEO1,721,298Jun 5, 20262
Alfieri MichaelPrincipal Financial Officer7,500Mar 19, 20261
Machatha StephenChief Development Officer221,799Aug 13, 20250
Joyce Martin JosephDirector23,967Jun 12, 20250
Edelman Joseph10% Owner5,875,851IndirectApr 7, 20250
Perceptive Advisors LLC10% Owner5,875,851IndirectApr 7, 20250
Perceptive Life Sciences Master Fund Ltd10% Owner5,875,851IndirectApr 7, 20250
Greenberg BruceSee Remarks126,382Aug 14, 20240
Reed JoshuaChief Financial Officer274,825Apr 1, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 5, 2026 (view filing)Jun 32 daysBrady Todd CPresident and CEOPPurchase+250.0K$1.67+$417.5K+17.0%1.72M after
Mar 20, 2026 (view filing)Mar 191 dayDouglas RichardDirectorPPurchase+70.0K$1.40+$98.0K+56.0%195.0K after
Mar 19, 2026 (view filing)Mar 181 dayAlfieri MichaelPrincipal Financial OfficerPPurchase+5.00K$1.42+$7.10K+200.0%7.50K after
Aug 15, 2025 (view filing)Aug 132 daysAlfieri MichaelPrincipal Financial OfficerPPurchase+2.50K$5.30+$13.3KNew position2.50K after
Aug 13, 2025 (view filing)Aug 112 daysMachatha StephenChief Development OfficerSSale−22.1K$5.15−$113.7K−9.1%221.8K after
Apr 7, 2025 (view filing)6:43 PM ETApr 34 daysEdelman Joseph and 2 others10% OwnerSSale−3.40M$1.42−$4.83M−36.7%5.88M after
Oct 21, 2024 (view filing)May 3, 2021-Apr 12, 20231,267 daysLateMiller-Rich NancyDirectorPPurchase+922$11.33+$10.4KNew position922 after2 lots
Aug 14, 2024 (view filing)Aug 122 daysMachatha StephenChief Development OfficerSSale−16.0K$4.74−$76.0K−6.3%236.8K after
Aug 14, 2024 (view filing)Aug 122 daysGreenberg BruceSee RemarksSSale−10.8K$4.74−$51.4K−7.9%126.4K after
Apr 17, 2024 (view filing)Mar 1236 daysMachatha StephenChief Development OfficerSSale−11.5K$3.16−$36.5K−4.4%252.8K afterAmended
Apr 17, 2024 (view filing)Mar 1137 daysGreenberg BruceSee RemarksSSale−13.2K$3.41−$45.0K−9.2%130.2K afterAmended
Apr 8, 2024 (view filing)5:32 PM ETApr 4-54 daysEdelman Joseph and 2 others10% OwnerPPurchase+178.0K$4.68+$833.9K+2.0%9.28M after2 lots
Apr 3, 2024 (view filing)5:22 PM ETApr 1-32 daysEdelman Joseph and 2 others10% OwnerPPurchase+504.3K$3.84+$1.93M+5.9%9.10M after3 lots
Mar 12, 2024 (view filing)Mar 11-121 dayBrady Todd CPresident and CEOSSale−183.2K$3.17−$580.4K−11.1%1.47M after2 lots
Oct 18, 2023 (view filing)5:15 PM ETOct 16-182 daysEdelman Joseph and 2 others10% OwnerSSale−2.76M$1.62−$4.45M−24.3%8.59M after2 lots
Aug 11, 2022 (view filing)4:08 PM ETAug 9-102 daysEdelman Joseph and 2 others10% OwnerPPurchase+115.0K$7.55+$867.8K+1.0%11.4M after2 lots
Aug 10, 2022 (view filing)4:10 PM ETAug 82 daysEdelman Joseph and 2 others10% OwnerPPurchase+97.0K$7.24+$702.3K+0.9%11.2M after
Aug 9, 2022 (view filing)4:08 PM ETAug 54 daysEdelman Joseph and 2 others10% OwnerPPurchase+141.0K$6.95+$980.0K+1.3%11.1M after
Aug 8, 2022 (view filing)4:09 PM ETAug 44 daysEdelman Joseph and 2 others10% OwnerPPurchase+95.1K$6.17+$586.8K+0.9%11.0M after
Aug 5, 2022 (view filing)4:10 PM ETAug 32 daysEdelman Joseph and 2 others10% OwnerPPurchase+100.0K$5.84+$584.0K+0.9%10.9M after
Aug 4, 2022 (view filing)4:10 PM ETAug 22 daysEdelman Joseph and 2 others10% OwnerPPurchase+412.4K$5.59+$2.31M+4.0%10.8M after
Aug 3, 2022 (view filing)5:16 PM ETAug 12 daysEdelman Joseph and 2 others10% OwnerPPurchase+144.2K$5.05+$728.1K+1.4%10.4M after
Aug 2, 2022 (view filing)4:27 PM ETJul 294 daysEdelman Joseph and 2 others10% OwnerPPurchase+222.1K$5.03+$1.12M+2.2%10.2M after
Aug 1, 2022 (view filing)5:37 PM ETJul 284 daysEdelman Joseph and 2 others10% OwnerPPurchase+119.4K$5.00+$597.0K+1.2%10.0M after
Jun 27, 2022 (view filing)Jun 234 daysJoyce Martin JosephDirectorPPurchase+4.32K$3.48+$15.0K+22.0%24.0K after
Jun 27, 2022 (view filing)Jun 234 daysBrady Todd CPresident and CEOPPurchase+17.7K$3.36+$59.5K+1.5%1.22M after